{"nctId":"NCT01253824","briefTitle":"Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers","startDateStruct":{"date":"2011-01"},"conditions":["Healthy"],"count":14,"armGroups":[{"label":"NPC-01","type":"EXPERIMENTAL","interventionNames":["Drug: NPC-01"]},{"label":"IKH-01","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: IKH-01"]}],"interventions":[{"name":"NPC-01","otherNames":["norethisterone and ethinyl estradiol"]},{"name":"IKH-01","otherNames":["norethisterone and ethinyl estradiol"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Healthy female aged between 20 to 35 years\n* BMI:18.0-26.0\n\nExclusion Criteria:\n\n* Females who are pregnant\n* Drug use affecting sex hormone secretion","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"20 Years","maximumAge":"35 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Comparing Estradiol AUC of Menstrual Period During Study Drug Administration With Pre and Post Study Drug Administration (Baseline(BL)-Study Drug Administration(SDA), Follow up(FU)-Study Drug Administration(ADA))","description":"Estradiol was measured on day 3, 6, 9, 12, 15, 18, 21, 24 on 3 consecutive menstrual period (pre administration/Baseline(BL), study drug administration(SDA), post administration/follow up(FU)) and calculated AUC from these data","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1654.7","spread":"1652.6"},{"groupId":"OG001","value":"2478.0","spread":"793.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1872.6","spread":"1819.2"},{"groupId":"OG001","value":"2434.9","spread":"1151.5"}]}]}]},{"type":"SECONDARY","title":"Comparing FSH AUC of Menstrual Period During Study Drug Administration With Pre and Post Study Drug Administration (Baseline(BL)-Study Drug Administration(SDA), Follow up(FU)-Study Drug Administration(ADA))","description":"FSH was measured on day 3, 6, 9, 12, 15, 18, 21, 24 on 3 consecutive menstrual period (pre administration/Baseline(BL), study drug administration(SDA), post administration/follow up(FU)) and calculated AUC from these data","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.609","spread":"20.879"},{"groupId":"OG001","value":"-4.380","spread":"18.034"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.404","spread":"41.309"},{"groupId":"OG001","value":"0.538","spread":"30.497"}]}]}]},{"type":"PRIMARY","title":"Comparing Progesterone AUC of Menstrual Period During Study Drug Administration With Pre and Post Study Drug Administration (Baseline(BL)-Study Drug Administration(SDA), Follow up(FU)-Study Drug Administration(ADA))","description":"Progesterone was measured on day 3, 6, 9, 12, 15, 18, 21, 24 on 3 consecutive menstrual period (pre administration/Baseline(BL), study drug administration(SDA), post administration/follow up(FU)) and calculated AUC from these data","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54.171","spread":"25.769"},{"groupId":"OG001","value":"93.148","spread":"45.867"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"89.711","spread":"47.882"},{"groupId":"OG001","value":"59.344","spread":"49.160"}]}]}]},{"type":"SECONDARY","title":"Comparing LH AUC of Menstrual Period During Study Drug Administration With Pre and Post Study Drug Administration (Baseline(BL)-Study Drug Administration(SDA), Follow up(FU)-Study Drug Administration(ADA))","description":"LH was measured on day 3, 6, 9, 12, 15, 18, 21, 24 on 3 consecutive menstrual period (pre administration/Baseline(BL), study drug administration(SDA), post administration/follow up(FU)) and calculated AUC from these data","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60.874","spread":"41.200"},{"groupId":"OG001","value":"57.124","spread":"50.821"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"61.571","spread":"89.546"},{"groupId":"OG001","value":"59.837","spread":"25.549"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":7},"commonTop":["Metrorrhagia","Oligomenorrhoea","Nasopharyngitis","Abdominal pain","Menorrhagia"]}}}